Dual Targeting of Akt and MAPK Pathways With Capivasertib and B‐Raf Inhibitors Synergistically Suppresses Tumor Growth in B‐Raf‐Mutated Melanoma Models

Fundamental and Clinical Pharmacology · Published 2026-04-21 · DOI 10.1111/fcp.70088

Authors being retrieved — see the publisher record. https://doi.org/10.1111/fcp.70088

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Differential Antipyretic Effects of Toll‐Like Receptor 4 Signal Inhibitors in Male Rats · Fundamental and Clinical Pharmacology · 2025 · Same journal
• Iohexol Clearance and Kidney Transplantation: Determinants of Its Variation in Living Kidney Donors One Year After Donation and Impact on Glomerular Filtration Rate Gain in Kidney Recipients · Fundamental and Clinical Pharmacology · 2026 · Same journal
• Repurposing Cimetidine as a Therapeutic Candidate for Irritable Bowel Syndrome in a Rat Model · Fundamental and Clinical Pharmacology · 2026 · Same journal
• Fluvoxamine Attenuates Liver Injury in Lipopolysaccharide‐Induced Sepsis: Via Nrf2/HO‐1 Pathway · Fundamental and Clinical Pharmacology · 2025 · Same journal
• TAAR1‐Associated Trace Amines for Cutaneous Nociceptive Blockade in Rats · Fundamental and Clinical Pharmacology · 2026 · Same journal
• SGLT‐2 Inhibitors Use in Hospitalized Patients in France: A Cross‐Sectional Study · Fundamental and Clinical Pharmacology · 2026 · Same journal
• The Challenges of Scientific Publishing: An Editor‐In‐Chief's Perspective · Fundamental and Clinical Pharmacology · 2026 · Same journal
• Comparative Analysis of Intrathecal Lidocaine Combined With Guanfacine or Dexmedetomidine on Nociceptive and Motor Blockade in Rats · Fundamental and Clinical Pharmacology · 2025 · Same journal
• Acute or Chronic β‐Caryophyllene Systemic Administration in Healthy Adult Male Mice Does Not Modulate Anxiety‐Like Extinction Behavior Induced by Subsequent Re‐Exposure to 3D Maze · Fundamental and Clinical Pharmacology · 2025 · Same journal
• Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data · Fundamental and Clinical Pharmacology · 2025 · Same journal